$OSUR
OraSure Technologies Inc

2013 Q2 Form 10-Q Financial Statement

#000119312513325636 Filed on August 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $24.34M $22.62M
YoY Change 7.61% 18.66%
Cost Of Revenue $9.838M $7.917M
YoY Change 24.26% 16.43%
Gross Profit $14.50M $14.70M
YoY Change -1.36% 19.89%
Gross Profit Margin 59.58% 64.99%
Selling, General & Admin $17.38M $15.13M
YoY Change 14.91% 59.56%
% of Gross Profit 119.88% 102.9%
Research & Development $2.693M $3.113M
YoY Change -13.49% -39.44%
% of Gross Profit 18.57% 21.18%
Depreciation & Amortization $1.619M $1.805M
YoY Change -10.3% 112.35%
% of Gross Profit 11.17% 12.28%
Operating Expenses $20.08M $18.24M
YoY Change 10.07% 24.75%
Operating Profit -$5.576M -$3.540M
YoY Change 57.51% 50.0%
Interest Expense $74.00K
YoY Change -205.71%
% of Operating Profit
Other Income/Expense, Net $42.00K -$113.0K
YoY Change -137.17% 1030.0%
Pretax Income -$5.534M -$3.653M
YoY Change 51.49% 49.71%
Income Tax -$249.0K -$91.00K
% Of Pretax Income
Net Earnings -$5.285M -$3.562M
YoY Change 48.37% 45.98%
Net Earnings / Revenue -21.72% -15.75%
Basic Earnings Per Share -$0.10 -$0.07
Diluted Earnings Per Share -$0.10 -$0.07
COMMON SHARES
Basic Shares Outstanding 55.56M shares 48.24M shares
Diluted Shares Outstanding 55.56M shares 48.24M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $77.00M $23.30M
YoY Change 230.47% -69.1%
Cash & Equivalents $76.96M $23.27M
Short-Term Investments
Other Short-Term Assets $365.0K $2.600M
YoY Change -85.96% 52.94%
Inventory $12.50M $11.00M
Prepaid Expenses
Receivables $15.36M $15.40M
Other Receivables $0.00 $0.00
Total Short-Term Assets $107.7M $52.30M
YoY Change 105.93% -46.08%
LONG-TERM ASSETS
Property, Plant & Equipment $18.14M $19.00M
YoY Change -4.54% -2.56%
Goodwill $24.02M
YoY Change
Intangibles $24.16M
YoY Change
Long-Term Investments
YoY Change
Other Assets $410.0K $100.0K
YoY Change 310.0% -66.67%
Total Long-Term Assets $66.72M $72.40M
YoY Change -7.84% 197.94%
TOTAL ASSETS
Total Short-Term Assets $107.7M $52.30M
Total Long-Term Assets $66.72M $72.40M
Total Assets $174.4M $124.7M
YoY Change 39.88% 2.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.381M $4.300M
YoY Change -21.37% 16.22%
Accrued Expenses $8.196M $7.900M
YoY Change 3.75% 11.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $7.000M
YoY Change -6.67%
Total Short-Term Liabilities $15.98M $20.80M
YoY Change -23.19% 3.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $383.0K $0.00
YoY Change
Total Long-Term Liabilities $383.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $15.98M $20.80M
Total Long-Term Liabilities $383.0K $0.00
Total Liabilities $16.36M $25.90M
YoY Change -36.83% 28.86%
SHAREHOLDERS EQUITY
Retained Earnings -$178.1M
YoY Change
Common Stock $335.9M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $154.6M $98.80M
YoY Change
Total Liabilities & Shareholders Equity $174.4M $124.7M
YoY Change 39.88% 2.8%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$5.285M -$3.562M
YoY Change 48.37% 45.98%
Depreciation, Depletion And Amortization $1.619M $1.805M
YoY Change -10.3% 112.35%
Cash From Operating Activities -$1.610M -$940.0K
YoY Change 71.28% -155.95%
INVESTING ACTIVITIES
Capital Expenditures $612.0K -$420.0K
YoY Change -245.71% 40.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$610.0K -$420.0K
YoY Change 45.24% -126.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -60.00K 1.800M
YoY Change -103.33% 13.92%
NET CHANGE
Cash From Operating Activities -1.610M -940.0K
Cash From Investing Activities -610.0K -420.0K
Cash From Financing Activities -60.00K 1.800M
Net Change In Cash -2.280M 440.0K
YoY Change -618.18% -90.95%
FREE CASH FLOW
Cash From Operating Activities -$1.610M -$940.0K
Capital Expenditures $612.0K -$420.0K
Free Cash Flow -$2.222M -$520.0K
YoY Change 327.31% -126.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55591658 shares
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
246000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23273000
CY2012Q2 osur Common Stock Options And Unvested Restricted Stock
CommonStockOptionsAndUnvestedRestrictedStock
6212000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55590000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55590000 shares
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8196000
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26871000
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1338000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3381000
CY2013Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
498000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
15977000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3251000
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3761000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2585000
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
383000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
154554000
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
335857000
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
204000
CY2013Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2599000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178052000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4400000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2520000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55281000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12815000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
174425000
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3511000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Assets Current
AssetsCurrent
107701000
CY2013Q2 us-gaap Goodwill
Goodwill
24017000
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24159000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
410000
CY2013Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
420000
CY2013Q2 us-gaap Assets
Assets
174425000
CY2013Q2 us-gaap Noncurrent Assets
NoncurrentAssets
18138000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76964000
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
6973000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15355000
CY2013Q2 us-gaap Inventory Net
InventoryNet
12497000
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
36974000
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
365000
CY2013Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
383000
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5104000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18138000
CY2013Q2 osur Entity Wide Revenue Major Customer Threshold Percentage
EntityWideRevenueMajorCustomerThresholdPercentage
0.10 pure
CY2013Q2 osur Common Stock Options And Unvested Restricted Stock
CommonStockOptionsAndUnvestedRestrictedStock
6011000 shares
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23878000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55281000 shares
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7960000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25846000
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1351000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3380000
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
413000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16920000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-666000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4248000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
89000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
170315000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
333522000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
285000
CY2012Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1948000
CY2012Q4 us-gaap Assets
Assets
191725000
CY2012Q4 us-gaap Noncurrent Assets
NoncurrentAssets
18546000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87888000
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-162541000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5580000
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11342000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
191725000
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4401000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Assets Current
AssetsCurrent
120403000
CY2012Q4 us-gaap Goodwill
Goodwill
25445000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
27207000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124000
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
393000
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6777000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17545000
CY2012Q4 us-gaap Inventory Net
InventoryNet
12758000
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
38550000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1719000
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
493000
CY2012Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
89000
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5588000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18546000
CY2012Q4 osur Number Of Significant Concentrations In Accounts Receivable
NumberOfSignificantConcentrationsInAccountsReceivable
1 Customer
dei Trading Symbol
TradingSymbol
OSUR
dei Entity Registrant Name
EntityRegistrantName
ORASURE TECHNOLOGIES INC
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001116463
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55504000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9278000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55504000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i><u>Use of Estimates</u>.</i> The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the valuation of accounts receivable and inventories and assumptions utilized in impairment testing for intangible assets and goodwill, as well as calculations related to contingencies and accruals, among others. These estimates and assumptions are based on management&#x2019;s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis, using historical experience and other factors which management believes to be reasonable under the circumstances, including the current economic environment. We adjust such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity and foreign currency markets, reductions in government funding and declines in consumer spending have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment and other factors will be reflected in the financial statements in those future periods.</font></p> </div>
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="PADDING-BOTTOM: 0px; MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><i><u>Deferred Revenue</u>.</i> We record deferred revenue when funds are received prior to the recognition of the associated revenue and when shipments of our OraQuick<font style="FONT-FAMILY: Times New Roman" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">&#xAE;</sup></font> In-Home HIV test are made to the retailers or distributors who have product return rights. Deferred revenue as of June&#xA0;30, 2013 and December&#xA0;31, 2012 included customer prepayments of $1,660 and $1,880, respectively, as well as $2,740 and $3,700, respectively, related to the OraQuick<font style="FONT-FAMILY: Times New Roman" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">&#xAE;</sup></font> In-Home HIV test, representing the estimated value of product held by those retailers or distributors having product return rights.</font></p> </div>
us-gaap Revenues
Revenues
45501000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
977000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18096000
us-gaap Gross Profit
GrossProfit
26528000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
28000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
45025000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2585000
us-gaap Operating Income Loss
OperatingIncomeLoss
-16165000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16170000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2585000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2030000
us-gaap License And Maintenance Revenue
LicenseAndMaintenanceRevenue
476000
us-gaap Net Income Loss
NetIncomeLoss
-15511000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-229000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
801000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1092000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1092000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10400000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-500000
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
0
us-gaap Cost Of Goods Sold
CostOfGoodsSold
18973000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-659000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1165000
us-gaap Share Based Compensation
ShareBasedCompensation
2835000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-10924000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26243000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
679000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1092000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6050000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
301000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3221000
us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
659000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
us-gaap Operating Expenses
OperatingExpenses
42693000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
40000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-659000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-54000
osur Percentage Of Excess Fair Value On Carrying Value
PercentageOfExcessFairValueOnCarryingValue
0.13 pure
osur Significant Concentrations In Revenues
SignificantConcentrationsInRevenues
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48021000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2296000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48021000 shares
us-gaap Interest Paid Net
InterestPaidNet
152000
us-gaap Revenues
Revenues
43560000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
476000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6568000
us-gaap Gross Profit
GrossProfit
28431000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
20000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
42077000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-85000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
250000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
246000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7191000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7425000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
246000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1764000
us-gaap License And Maintenance Revenue
LicenseAndMaintenanceRevenue
1483000
us-gaap Net Income Loss
NetIncomeLoss
-6814000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1401000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1486000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
730000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
730000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12178000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2394000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
15129000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-611000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
243000
us-gaap Share Based Compensation
ShareBasedCompensation
2521000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-605000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16888000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1287000
us-gaap Interest Expense
InterestExpense
149000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
151000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-730000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6556000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4130000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3614000
us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
611000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
us-gaap Operating Expenses
OperatingExpenses
35622000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-611000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
27000
osur Significant Concentrations In Revenues
SignificantConcentrationsInRevenues
0
CY2012 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.11 pure
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48235000 shares
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48235000 shares
CY2012Q2 us-gaap Revenues
Revenues
22616000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4422000
CY2012Q2 us-gaap Gross Profit
GrossProfit
14699000
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
22339000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-39000
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-860000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3540000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3653000
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-860000
CY2012Q2 us-gaap License And Maintenance Revenue
LicenseAndMaintenanceRevenue
277000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-3562000
CY2012Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
424000
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6112000
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7917000
CY2012Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9014000
CY2012Q2 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2012Q2 us-gaap Interest Expense
InterestExpense
74000
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3113000
CY2012Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1805000
CY2012Q2 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
91000
CY2012Q2 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
18239000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-91000
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55559000 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55559000 shares
CY2013Q2 us-gaap Revenues
Revenues
24337000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6745000
CY2013Q2 us-gaap Gross Profit
GrossProfit
14499000
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
24063000
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
42000
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1460000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5576000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5534000
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1460000
CY2013Q2 us-gaap License And Maintenance Revenue
LicenseAndMaintenanceRevenue
274000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-5285000
CY2013Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
612000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5013000
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
9838000
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12369000
CY2013Q2 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2693000
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1619000
CY2013Q2 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
249000
CY2013Q2 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
20075000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-249000

Files In Submission

Name View Source Status
0001193125-13-325636-index-headers.html Edgar Link pending
0001193125-13-325636-index.html Edgar Link pending
0001193125-13-325636.txt Edgar Link pending
0001193125-13-325636-xbrl.zip Edgar Link pending
d565368d10q.htm Edgar Link pending
d565368dex311.htm Edgar Link pending
d565368dex312.htm Edgar Link pending
d565368dex321.htm Edgar Link pending
d565368dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
osur-20130630.xml Edgar Link completed
osur-20130630.xsd Edgar Link pending
osur-20130630_cal.xml Edgar Link unprocessable
osur-20130630_def.xml Edgar Link unprocessable
osur-20130630_lab.xml Edgar Link unprocessable
osur-20130630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending